|
Market Cap (24-Jun) $3,159,507 (1,963rd) |
Close (30-Jun) $0.028 |
Volume (30-Jun) 42,322 |
Shortsold (5-Apr) 9,554 (0.01%) (569th) |
|
52w High $0.020 |
52w Low $0.005 |
P/E - |
EPS -0.01 |
ANR released this announcement to the ASX on 27 October 2020, 11:30. The announcement is not marked as price sensitive, and is 24 page(s) in length and 513.94kb in size.
You can view all announcements from ANR and see how they appear on a price chart on the announcements page.
At the date of this announcement, ANR was 0.075% short sold according to ASIC data. It was ranked the 425th most shorted stock on the ASX. It remains ranked 569th as of the latest reported data (05 April 2024).
| Other Recent Announcements from ANR | |
|---|---|
| Anatara Update on GaRP Irritable Bowel Syndrome Trial | 6 June 2023, 8:19 |
| Anatara Investor Presentation | 8 May 2023, 10:44 |
| Registered Office Change | 20 April 2023, 11:51 |
| Appendix 4G and Corporate Governance Statement | 27 October 2020, 11:30 |
| Annual Report to shareholders | 27 October 2020, 11:28 |
| Proposed issue of Securities - ANR | 21 October 2020, 11:39 |
| Proposed issue of Securities - ANR | 21 October 2020, 11:04 |
You must be logged in to post a reply.
Anatara Lifesciences 